Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, isolates those companies that are best positioned to succeed.
Here are today's top performing health care Small-Cap Stars:
Galectin Therapeutics Inc. (GALT)
Galectin Therapeutics Inc. gained 10.9% to $13.53. The gains came on a volume of 261,373 shares against an average daily volume of 306,630 shares. Galectin Therapeutics Inc. has had a trading range from $19.1099 to $4.55 over the last year, it has a 50-day SMA of $12.89, and a 200-day SMA of $12.
Galectin Therapeutics, Inc. is a development-stage company engaged in drug research and development to create new therapies for fibrotic disease and cancer.
Dyax Corp. (DYAX)
Dyax Corp. gained 8.72% to $8.85. The gains came on a volume of 1,106,250 shares against an average daily volume of 1,156,430 shares. Dyax Corp. has had a trading range from $10.99 to $3.68 over the last year, it has a 50-day SMA of $8.1, and a 200-day SMA of $8.14.
Dyax Corp is a biotechnology company, which is engaged in the discovery, development and commercialization of biopharmaceuticals for unmet medical needs.
Idera Pharmaceuticals Inc. (IDRA)
Idera Pharmaceuticals Inc. gained 7.87% to $2.74. The gains came on a volume of 1,251,320 shares against an average daily volume of 1,913,303 shares. Idera Pharmaceuticals Inc. has had a trading range from $6.874 to $0.73 over the last year, it has a 50-day SMA of $2.85, and a 200-day SMA of $3.44.
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company engaged in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
Inovio Pharmaceuticals Inc. (INO)
Inovio Pharmaceuticals Inc. gained 7.75% to $10.15. The gains came on a volume of 1,028,890 shares against an average daily volume of 2,051,995 shares. Inovio Pharmaceuticals Inc. has had a trading range from $15.8 to $4.8 over the last year, it has a 50-day SMA of $9.37, and a 200-day SMA of $10.02.
Inovio Pharmaceuticals, Inc. is a biomedical company, engaged in the development of next-generation vaccines to prevent or treat cancers and chronic infectious diseases.
Tg Therapeutics Inc. (TGTX)
Tg Therapeutics Inc. gained 7.41% to $9.71. The gains came on a volume of 542,035 shares against an average daily volume of 618,202 shares. Tg Therapeutics Inc. has had a trading range from $11.56 to $2.97 over the last year, it has a 50-day SMA of $7.67, and a 200-day SMA of $5.73.
TG Therapeutics Inc is a biopharmaceutical company focused on the acquisition, development & commercialization of medically important pharmaceutical products for the treatment of cancer & other underserved therapeutic needs.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
No one can predict precisely which potential treatments will fly through their clinical trials and which will stumble along the way. At least, if someone can, they're undoubtedly spectacularly wealthy right now. But, while the science is clearly the most important factor for the success of a small-cap biotech company, it's not the only one.
Equities.com's Small-Cap Stars system uses a complicated statistical regression to determine which fundamental factors previous success stories had in common and then identifies those present health care small caps that share those traits. For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most important qualities in predicting the potential success of a company.